Novartis to acquire inflammasome-focused IFM Tre
Monday, April 1, 2019 - 05:40
in Mathematics & Economics
The big company is bolstering its portfolio with three NLRP3 antagonists
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via